A detailed history of Ashton Thomas Private Wealth, LLC transactions in Incyte Corp stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 24,494 shares of INCY stock, worth $2.55 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
24,494
Previous 28,707 14.68%
Holding current value
$2.55 Million
Previous $1.95 Billion 6.26%
% of portfolio
0.05%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$67.27 - $86.96 $283,408 - $366,362
-4,213 Reduced 14.68%
24,494 $2.08 Billion
Q2 2025

Jul 31, 2025

SELL
$55.17 - $71.22 $27,143 - $35,040
-492 Reduced 1.68%
28,707 $1.95 Billion
Q1 2025

May 15, 2025

BUY
$60.0 - $75.26 $1.13 Million - $1.42 Million
18,818 Added 181.27%
29,199 $1.77 Billion
Q4 2024

Feb 06, 2025

BUY
$65.08 - $83.38 $675,595 - $865,567
10,381 New
10,381 $717 Million
Q2 2024

Aug 06, 2024

BUY
$51.18 - $63.75 $3,019 - $3,761
59 New
59 $3.58 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ashton Thomas Private Wealth, LLC Portfolio

Follow Ashton Thomas Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.